Drug Shortage Report for ROFACT

Last updated on 2020-04-23 History
Report ID 111785
Drug Identification Number 00393444
Brand name ROFACT
Common or Proper name ROFACT
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) RIFAMPIN
Strength(s) 150MG
Dosage form(s) CAPSULE
Route of administration ORAL ORAL
Packaging size 100's
ATC code J04AB
ATC description DRUGS FOR TREATMENT OF TUBERCULOSIS
Reason for shortage Demand increase for the drug.
Anticipated start date 2020-04-24
Actual start date
Estimated end date
Actual end date 2020-04-21
Shortage status Avoided shortage
Updated date 2020-04-23
Company comments currently on manual allocation
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2020-04-09 English Compare
v2 2020-04-09 French Compare
v3 2020-04-23 English Compare
v4 2020-04-23 French Compare

Showing 1 to 4 of 4